Received Jun 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENACTRA) | SANOFI PASTEUR | UNK | U6455CA | OT |
a men b immunization was charted in the hcp's system, but the patient should not have had men b at their particular age with no reported adverse event; Initial information received on 27-May-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves child of unknown age and is reported meningococcal A-C-Y-W135 (D CONJ) vaccine [Menactra] immunization was charted in the hcp's (healthcare progessional) system, but the patient should not have had men b at their particular age with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, suspect Meningococcal A-C-Y-W135 (D CONJ) Vaccine Solution for injection of lot U6455CA and expiry date: 15-Nov-2020 (strength, dose: not reported) via unknown route in unknown administration site for immunization was charted in the hcp's system, but the patient should not have had men b at their particular age with no reported adverse event (product administered to patient of inappropriate age) (latency: on same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.